Acquired
Novo Nordisk (Ozempic)
Ben Gilbert
It's a great question. Thanks to Alex, we have the data right in front of us. So here's the probability that a preclinical study even makes it to the phases. That's 69%. So... You're a little over two-thirds once you enter a preclinical study to graduate to phase one, two, and three. But in phase one, two, and three, about half of them get weeded out each time.
0
💬
0
Comments
Log in to comment.
There are no comments yet.